Search
for
Sort by
Research 601–630 of 876
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Baricitinib: A Review in Severe Alopecia Areata
- Drug-Induced Hair Changes
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Real-world evidence in alopecia areata treatment: A narrative review
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Enhancing hair regrowth in Alopecia areata: the power duo of CO2 fractional laser and Bimatoprost
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil
- Bimatoprost versus clobetasol propionate in scalp alopecia areata: A prospective non-randomized open-label clinical trial
- Application and Approach to Hair Transplantation in Females
- A retrospective analysis of efficacy and safety of intralesional triamcinolone injections in the treatment of frontal fibrosing alopecia either as monotherapy or as a concomitant therapy
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps.
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Cancer-Related Alopecia Risk and Treatment
- Bimatoprost Can Increase Growth and Density of Eyebrow Hair: A Prospective Study on a Group of Young Women
- Frontal fibrosing alopecia: follow-up of a brazilian group
- Baricitinib for the Treatment of Alopecia Areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia
- Loose anchoring of anagen hairs and pili torti due to erlotinib
- Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study
- Minimally Invasive Removal of Leukotrichia and Hair Transplantation: A 2-Step Surgery in the Treatment of Stable Follicular Vitiligo
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Alopecia Areata of the Nails: Diagnosis and Management